Myeloid leukemia C-1498 as a screen for cancer chemotherapeutic agents.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001375:Azaguanine / Q000627:therapeutic use; D001377:Azaserine / Q000627:therapeutic use; D002066:Busulfan / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D005260:Female; D005467:Floxuridine / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D007942:Leukemia, Experimental / Q000188:drug therapy*; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D011720:Pyrazoles / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D014265:Triethylenemelamine / Q000627:therapeutic use; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D011720:Pyrazoles; D011743:Pyrimidines; D005467:Floxuridine; D003609:Dactinomycin; D014750:Vincristine; D014747:Vinblastine; D001377:Azaserine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D014265:Triethylenemelamine; D002066:Busulfan; D001375:Azaguanine; D005472:Fluorouracil; D011241:Prednisone; D008727:Methotrexate